Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Automatic Implantable Cardiac Defibrillators.

Steven L. Higgins1

  • 1Regional Cardiac Arrhythmia Center, Scripps Memorial Hospital, 9850 Genesee Avenue, #940, La Jolla, CA 92037, USA. EPdoc@cardiacarrhythmia.org

Current Treatment Options in Cardiovascular Medicine
|July 3, 2002
PubMed
Summary
This summary is machine-generated.

Automatic implantable cardioverter defibrillators (ICDs) have evolved significantly, expanding their use beyond cardiac arrest survivors to improve survival in heart failure patients. These advanced devices now offer comprehensive arrhythmia management and heart failure support.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • The automatic implantable cardioverter defibrillator (ICD) was first used in humans in 1980.
  • Initial indications were limited to patients with a history of cardiac arrest.
  • Significant technological advancements have broadened the scope and acceptance of ICDs.

Purpose of the Study:

  • To review the evolution and expanded indications of automatic implantable cardioverter defibrillators (ICDs).
  • To highlight the impact of technological advancements on ICD therapy.
  • To emphasize the current role of ICDs in managing life-threatening arrhythmias and heart failure.

Main Methods:

  • Review of historical data and recent clinical findings on ICDs.
  • Analysis of technological miniaturization and implantation techniques.
  • Examination of expanded therapeutic capabilities beyond defibrillation.

Main Results:

  • ICDs have progressed from treating only survivors of cardiac arrest to improving survival in patients with myocardial infarction and low ejection fraction.
  • Miniaturization has led to transvenous implantation and shorter hospital stays.
  • Current ICDs manage ventricular and atrial arrhythmias, support heart failure management, and offer pacemaker functionalities.

Conclusions:

  • The automatic implantable cardioverter defibrillator (ICD) is now standard therapy for preventing life-threatening arrhythmias.
  • Technological progress has dramatically expanded the indications for ICD implantation.
  • Modern ICDs provide comprehensive cardiac rhythm management and heart failure support.